Clinical Trial Update: Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients [Phase 4]

View source ↗

Summary

Phase 4 study assessing immune responses to the influenza A H1N1/09 vaccine in high-risk patients, including those with HIV infection and rheumatic disease; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Rheumatic Disease

Drugs mentioned

• Influenza A(H1N1) vaccine (Influenza A(H1N1) vaccine)

Snippet

Sponsor: University Hospital, Geneva | Conditions: HIV Infection, Rheumatic Disease | Phase 4 | Status: COMPLETED